These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 33353081)

  • 1. Real World Use of Antidiabetic Drugs in the Years 2011-2017: A Population-Based Study from Southern Italy.
    Ingrasciotta Y; Bertuccio MP; Crisafulli S; Ientile V; Muscianisi M; L'Abbate L; Pastorello M; Provenzano V; Scorsone A; Scondotto S; Trifirò G
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33353081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: a population-based study.
    Rafaniello C; Arcoraci V; Ferrajolo C; Sportiello L; Sullo MG; Giorgianni F; Trifirò G; Tari M; Caputi AP; Rossi F; Esposito K; Giugliano D; Capuano A
    Diabetes Res Clin Pract; 2015 Apr; 108(1):157-63. PubMed ID: 25686508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy.
    Trifirò G; Parrino F; Pizzimenti V; Giorgianni F; Sultana J; Muscianisi M; Troncone C; Tari DU; Arcoraci V; Santoro D; Russo G; Lacava V; Caputi AP
    Clin Drug Investig; 2016 Mar; 36(3):203-12. PubMed ID: 26692008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy.
    Orlando V; Guerriero F; Putignano D; Monetti VM; Tari DU; Farina G; Illario M; Iaccarino G; Menditto E
    Curr Diabetes Rev; 2015; 12(2):100-6. PubMed ID: 26126718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Losada E; Soldevila B; Ali MS; Martínez-Laguna D; Nogués X; Puig-Domingo M; Díez-Pérez A; Mauricio D; Prieto-Alhambra D
    Osteoporos Int; 2018 Sep; 29(9):2079-2086. PubMed ID: 29860664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study.
    Nishimura R; Kato H; Kisanuki K; Oh A; Hiroi S; Onishi Y; Guelfucci F; Shimasaki Y
    BMJ Open; 2019 Mar; 9(3):e025806. PubMed ID: 30826768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study.
    Overbeek JA; Heintjes EM; Prieto-Alhambra D; Blin P; Lassalle R; Hall GC; Lapi F; Bianchini E; Hammar N; Bezemer ID; Herings RMC
    Clin Ther; 2017 Apr; 39(4):759-770. PubMed ID: 28342563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens.
    Vittorino Gaddi A; Benedetto D; Capello F; Di Pietro C; Cinconze E; Rossi E; De Sando V; Cevenini M; D'Alò G
    Public Health; 2014 Jan; 128(1):70-6. PubMed ID: 23969148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.
    Grimes RT; Bennett K; Tilson L; Usher C; Smith SM; Henman MC
    Br J Clin Pharmacol; 2015 Jun; 79(6):1000-9. PubMed ID: 25521800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to modification of antidiabetic therapy in patients over the age of 65 years with newly diagnosed diabetes mellitus.
    Machado-Alba JE; Machado-Duque ME; Gaviria-Mendoza A
    Diabetes Res Clin Pract; 2020 Apr; 162():108090. PubMed ID: 32088311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany-A retrospective analysis of real-world data.
    Dombrowski S; Kostev K; Jacob L
    Osteoporos Int; 2017 Aug; 28(8):2421-2428. PubMed ID: 28455750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Therapeutic Choices and Adherence to Antidiabetic Therapy in Naïve Patients: A Retrospective Observational Study in a Local Health Authority of the Piedmont Region (Italy).
    Armando LG; Miglio G; Baroetto Parisi R; Esiliato M; Rolando C; Vinciguerra V; Diarassouba A; Cena C
    Healthcare (Basel); 2023 Jun; 11(11):. PubMed ID: 37297798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Patterns of Diabetes in Italy: A Population-Based Study.
    Moreno Juste A; Menditto E; Orlando V; Monetti VM; Gimeno Miguel A; González Rubio F; Aza-Pascual-Salcedo MM; Cahir C; Prados Torres A; Riccardi G
    Front Pharmacol; 2019; 10():870. PubMed ID: 31447672
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression.
    Lunghi C; Zongo A; Moisan J; Grégoire JP; Guénette L
    J Diabetes Complications; 2017 Jul; 31(7):1200-1206. PubMed ID: 28325698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Patient-Related Variables Associated with Initiating GLP-1 Receptor Agonist Therapy in Type 2 Diabetes Patients in Primary Care in Germany.
    Qiao Q; Grandy S; Hiller J; Kostev K
    PLoS One; 2016; 11(3):e0152281. PubMed ID: 27019360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.
    Athyros VG; Polyzos SA; Kountouras J; Katsiki N; Anagnostis P; Doumas M; Mantzoros CS
    Curr Vasc Pharmacol; 2020; 18(2):172-181. PubMed ID: 30961499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
    Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
    J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis.
    Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
    J Med Econ; 2016 Jul; 19(7):655-62. PubMed ID: 26855139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.